AQR Capital Management’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10.3M | Sell |
|
|||||
|
2025
Q1 | $9.01M | Buy |
|
|||||
|
2024
Q4 | $6.31M | Buy |
|
|||||
|
2024
Q3 | $5.98M | Buy |
|
|||||
|
2024
Q2 | $3.36M | Buy |
|
|||||
|
2024
Q1 | $2.32M | Buy |
|
|||||
|
2023
Q4 | $2.24M | Buy |
|
|||||
|
2023
Q3 | $521K | Buy |
|
|||||
|
2023
Q2 | $268K | Sell |
|
|||||
|
2023
Q1 | $324K | Buy |
|
|||||
|
2022
Q4 | $287K | Buy |
|
|||||
|
2022
Q3 | $284K | Sell |
|
|||||
|
2022
Q2 | $317K | Sell |
|
|||||
|
2022
Q1 | $922K | Sell |
|
|||||
|
2021
Q4 | $1.37M | Sell |
|
|||||
|
2021
Q3 | $1.87M | Buy |
|
|||||
|
2021
Q2 | $1.71M | Buy |
|
|||||
|
2021
Q1 | $624K | Sell |
|
|||||
|
2020
Q4 | $464K | Sell |
|
|||||
|
2020
Q3 | $356K | Sell |
|
|||||
|
2020
Q2 | $565K | Buy |
|
|||||
|
2020
Q1 | $42K | Sell |
|
|||||
|
2019
Q4 | $164K | Buy |
|
|||||
|
2019
Q3 | $75K | Sell |
|
|||||
|
2019
Q2 | $164K | Sell |
|
|||||
|
2019
Q1 | $382K | Buy |
|
|||||
|
2018
Q4 | $361K | Buy |
|
|||||
|
2018
Q2 | – | Sell |
|
|||||
|
2018
Q1 | $139K | Sell |
|
|||||
|
2017
Q4 | $261K | Sell |
|
|||||
|
2017
Q3 | $346K | Buy |
|
|||||
|
2017
Q2 | $302K | Buy |
|
|||||
|
2017
Q1 | $351K | Buy |
|
|||||
|
2016
Q3 | – | Sell |
|
|||||
|
2016
Q2 | $278K | Sell |
|
|||||
|
2016
Q1 | $353K | Buy |
|
|||||
|
2015
Q4 | $254K | Sell |
|
|||||
|
2015
Q3 | $614K | Buy |
|
|||||
|
2015
Q2 | $329K | Sell |
|
|||||
|
2015
Q1 | $2.06M | Sell |
|
|||||
|
2014
Q4 | $5.78M | Buy |
|
|||||
|
2014
Q3 | $3.35M | Buy |
|
|||||
|
2014
Q2 | $1.44M | Buy |
|
|||||
|
2014
Q1 | $1.18M | Buy |
|
|||||
|
2013
Q4 | $724K | Buy |
|